LED Medical Diagnostics Announces Grant of Options

LED Medical Diagnostics Inc. (TSX VENTURE:LMD) ("LED" or the "Company")
announces that it has granted a total of 448,000 incentive stock options to
consultants of the Company. Each stock option is exercisable to acquire one
Common Share of the Company at $0.40 per share and can be exercised for a 3 year
term. The option grants are subject to regulatory approval. 


About LED Medical Diagnostics Inc.

Headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc.
is a leading developer of LED-based visualization technologies for the medical
industry. The company is publicly traded on the TSX.V under the symbol LMD. 


Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures
the VELscope Vx Enhanced Oral Assessment System, the first system in the world
to apply tissue fluorescence visualization technology to the oral cavity.
VELscope Vx devices are now used to conduct more screenings for oral cancer and
other oral diseases than any other adjunctive device. To date, there have been
more than 12,000 VELscope Vx systems sold globally and they have been used to
perform more than 25 million exams. For more information, visit
www.velscope.com.


FOR FURTHER INFORMATION PLEASE CONTACT: 
LED Medical Diagnostics Inc.
Mark Komonoski, Investor Relations
[phone] or Toll-Free: [phone]
Cell: [phone]
[e-mail]
Skype: mkomonoski